Celldex Therapeutics

Call
Website
160 Gould St Ste 202
Needham Heights, MA 02494
+1 (781) 433-0771
https://www.celldex.com
Celldex Therapeutics is a biopharmaceutical company that applies its Immunotherapy Platform to treat various diseases. Its immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates. Celldex Therapeutics technology platform uses human monoclonal antibodies administered directly to patients to target dendritic cells and macrophages that are key cells in the immune system. Its APC Targeting Technology delivers an antigen that results in more efficient processing than a nontargeted antigen. The company develops various therapeutic human monoclonal antibody products. Its lead programs are for oncology targets. Celldex Therapeutics has two clinical programs under clinical evaluation for the therapy of cancer.

Also at this address

Own this business?
See a problem?

You might also like

Biomodels
Services, nec, nec, Business services, nec, nec, Blood derivatives

Biomodels

Biomodels in Waltham offers a wide range of preclinical research services, specializing in contract services for biopharmaceutical companies. Their experienced team provides comprehensive preclinical CRO services to support the development of innovative therapies and drug candidates. Generated from their website's infomation
Drugs acting on the respiratory system, Blood derivatives, Surgical instruments and apparatus

Relay Therapeutics

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.
Medical research, Blood derivatives

Translate Bio, Inc

Translate Bio is a biotechnology company based in Lexington, MA that focuses on developing mRNA therapeutics for various diseases. The company's research and development efforts are centered around leveraging mRNA technology to create potential treatments for a range of medical conditions. Translate Bio's work in the field of mRNA therapeutics aims to address unmet medical needs and advance the understanding of this innovative approach to healthcare. Through its research initiatives, the company seeks to contribute to the advancement of personalized medicine and improve patient outcomes. Generated from their business information
United States›Massachusetts›Needham Heights›Celldex Therapeutics

Partial Data by Infogroup (c) 2025. All rights reserved.